共 50 条
- [23] A Phase 1/2 Study to Evaluate Ponatinib With Chemotherapy in Pediatric Patients With Relapsed/Resistant/Intolerant Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or With T315I Mutation CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S190 - S191